Although the significance of the chaperones that interplay in AD pathology remains unclear, increasing evidence suggests that Hsp–ubiquitin–proteasome system (UPS)-mediated aggregate clearance plays a pivotal role in the AD pathology and further emphasizes the role of Hsp90 as a mediator of tau protein regulation and degradation16. This evidence concerns the gene MAPT and Alzheimer disease.